YTHDF2 expression is inversely associated with overall survival in hepatocellular carcinoma patients, indicating a poor prognostic signature, and the knockdown of YTHDF2 leads to impaired stemness. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.